Related Experiment Videos
[Fulminant hepatitis B]
Milomir Dokić1, Vesna Begović, Radmila Rajić-Dimitrijević
1Vojnomedicinska akademija, Klinika za infektivne i tropske bolesti, Beograd.
Vojnosanitetski Pregled
|August 2, 2003
Summary
Fulminant hepatitis, a severe liver impairment causing coma, can sometimes resolve spontaneously with intensive care. This paper presents two survival cases of fulminant B hepatitis, highlighting intensive treatment
Area of Science:
- Hepatology
- Critical Care Medicine
- Virology
Background:
- Fulminant hepatitis, or fulminant hepatic failure, is a severe clinical syndrome characterized by rapid liver dysfunction.
- It leads to hepatic coma and impaired liver synthesis capacity, developing within eight weeks of hepatitis onset.
- Patient survival is influenced by age, etiology, encephalopathy severity/duration, and complication management.
Observation:
- Two cases of fulminant B hepatitis with unfavorable prognoses are presented.
- These patients received intensive care treatment, including corticosteroids.
- Both patients survived despite the initial poor outlook.
Findings:
- Intensive monitoring and therapeutic interventions, such as corticosteroids, are crucial for managing fulminant hepatitis.
- Spontaneous recovery and a normal life are possible without liver transplantation.
- Prognosis without transplantation is currently limited by available medical treatments.
Implications:
- Further basic research is needed to develop novel therapeutic modalities for fulminant hepatitis.
- Exploring new treatments could improve survival rates and reduce reliance on expensive liver transplantation.
- Understanding spontaneous recovery mechanisms may offer insights into non-transplant-based treatment strategies.